Viliam Bugan
Impact in
- Surgery top 10%
- Lipoproteins and Cardiovascular Health
- Coronary Interventions and Diagnostics
-
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Heart Failure Treatment and Management
Papers in
- Surgery 6
- Lipoproteins and Cardiovascular Health 6
-
- Heart Failure Treatment and Management 2
- Antiplatelet Therapy and Cardiovascular Diseases 1
Viliam Bugan
9 papers receiving 654 citations
Viliam Bugan's Hit Papers
Peers
Comparison fields: 5 of 47
- Surgery 403
- Cardiology and Cardiovascular Medicine 197
- Endocrinology, Diabetes and Metabolism 118
- Immunology 20
- Nephrology 10
Countries citing papers authored by Viliam Bugan
This map shows the geographic impact of Viliam Bugan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viliam Bugan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viliam Bugan more than expected).
Fields of papers citing papers by Viliam Bugan
This network shows the impact of papers produced by Viliam Bugan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viliam Bugan. The network helps show where Viliam Bugan may publish in the future.
No co-authors to show.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial Hit paper breakdown → | 2019 | 244 |
| 2 | 2019 | 160 | |
| 3 | 2021 | 116 | |
| 4 | 2022 | 78 | |
| 5 | 2020 | 30 | |
| 6 | 2021 | 28 | |
| 7 | Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES Hit paper breakdown → | 2025 | 19 |
| 8 | 2024 | 15 | |
| 9 | 2021 | 13 |
About Viliam Bugan
Viliam Bugan is a scholar working on Surgery, Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 9 papers that have together received 703 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (6 papers), Heart Failure Treatment and Management (2 papers), Diabetes Treatment and Management (1 paper) and Antiplatelet Therapy and Cardiovascular Diseases (1 paper). The work is most often cited by research in Surgery (403 citations), Cardiology and Cardiovascular Medicine (197 citations), Endocrinology, Diabetes and Metabolism (118 citations), Immunology (20 citations) and Nephrology (10 citations). Their work appears in journals such as Diabetes Care, Circulation, The Lancet, European Heart Journal - Cardiovascular Pharmacotherapy and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.